Timothy Hoey
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Timothy Hoey served as the Director of the Biology Department at Amgen, Inc. and Tularik, Inc. He then became the Co-Chief Scientific Officer & SVP of Cancer Biology at Mereo BioPharma 5, Inc. from 2016 to 2017.
Currently, he is the Chief Scientific Officer at Tenaya Therapeutics, Inc. Dr. Hoey holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 05/03/2024 | 245 346 ( 0.31% ) | 1 M $ | 31/05/2024 |
Precedenti posizioni note di Timothy Hoey
| Società | Posizione | Fine |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/06/2024 |
| ONCOMED PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 14/12/2011 |
Formazione di Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Timothy Hoey
